Medistim ASA reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was NOK 117.5 million compared to NOK 104.48 million a year ago. Revenue was NOK 117.5 million compared to NOK 109.77 million a year ago. Net income was NOK 33.12 million compared to NOK 34.17 million a year ago. Basic earnings per share from continuing operations was NOK 1.82 compared to NOK 1.88 a year ago. Diluted earnings per share from continuing operations was NOK 1.81 compared to NOK 1.87 a year ago.
For the six months, sales was NOK 233.62 million compared to NOK 207.11 million a year ago. Revenue was NOK 233.62 million compared to NOK 212.4 million a year ago. Net income was NOK 56.85 million compared to NOK 55.99 million a year ago. Basic earnings per share from continuing operations was NOK 3.12 compared to NOK 3.07 a year ago. Diluted earnings per share from continuing operations was NOK 3.11 compared to NOK 3.07 a year ago.